|
|
|
|
Semcan Inc. Announces Management Change at Naston Limited
Semcan Inc.(TSX VENTURE: STT) ('Semcan' or the 'Company') announced today that Mr. Glenn Huntington has been relieved of his duties as Managing Director of the Company's wholly-owned United Kingdom subsidiary, Naston Limited. A...
|
|
|
Report From a National Tobacco Dependence Survey of Psychiatric Nurses
Use of Antiemetic Agents in Acute Gastroenteritis 3.Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. Report From a National Tobacco Dependence Survey of Psychiatric Nurses.<...
|
|
|
Ghrelin May Play Role in Alcohol Dependence
THURSDAY, July 2 (HealthDay News) -- In addition to its already known function in the regulation of eating, central ghrelin signaling appears to be necessary for the rewarding properties of alcohol, according to research published online...
|
|
|
Experts Available to Comment on Chantix and Zyban
Newswise If you are covering the story on the Food and Drug Administrations new requirement for manufacturers to put a boxed warning on the prescribing information for the smoking cessation medications Chantix and Zyban, experts at the...
|
|
|
Rebound Acid Reflux with PPIs May Induce Dependence
SAN FRANCISCO, July 2 -- Proton-pump inhibitors may cause or aggravate the very acid-reflux symptoms they're used to treat, according to a randomized trial.After a two-month course of esomeprazole (Nexium), 44% of asymptomatic, healthy...
|
|
|
Swedish Discovery May Provide New Treatments For Alcohol Dependence
Researchers at the Sahlgrenska Academy, Gothenburg, have discovered a new brain mechanism involved in alcohol addiction involving the stomach hormone ghrelin.When ghrelin's actions in the brain are blocked, alcohol's effects on the reward...
|
|
|
Discovery May Provide New Treatments for Alcohol Dependence
Researchers at the Sahlgrenska Academy, Gothenburg, have discovered a new brain mechanism involved in alcohol addiction involving the stomach hormone ghrelin.When ghrelins actions in the brain are blocked, alcohols effects on the reward...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Th
ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc.(NYSE: KG) today announced that the Company is presenting safety...
|
|
|
King Pharmaceuticals Showcases Data from Pain Pipeline of Medicines Designed To Deter Common Methods of Non-Th
Print Save in My Library Free Full Text King Pharmaceuticals, Inc.announced that the Company is presenting safety and efficacy data for ACUROX and EMBEDA, two novel opioid analgesic formulations that are in development, at the 71st Annual...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Th
ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc.(NYSE: KG) today announced that the Company is presenting safety...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Th
ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc.(NYSE: KG) today announced that the Company is presenting safety...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Th
ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc.(NYSE: KG) today announced that the Company is presenting safety...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Th
ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc.(NYSE: KG) today announced that the Company is presenting safety...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Th
ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc.(NYSE: KG) today announced that the Company is presenting safety...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Th
ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc.(NYSE: KG) today announced that the Company is presenting safety...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Th
ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc.(NYSE: KG) today announced that the Company is presenting safety...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Th
ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc.(NYSE: KG) today announced that the Company is presenting safety...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Th
ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc.today announced that the Company is presenting safety and efficacy...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Th
ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc.(NYSE:KG) today announced that the Company is presenting safety...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Th
Source: King Pharmaceuticals, Inc.Buzz up! Companies: ACUROX and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting Related Quotes {'s' : 'kg','k' : 'c10,l10,p20,t10','o' : '','j' : ''} RENO,...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Th
King Pharmaceuticals, Inc.(NYSE: KG) today announced that the Company is presenting safety and efficacy data for ACUROX(R) and EMBEDA(TM) (ALO-01), two novel opioid analgesic formulations that are in development, at the 71st Annual...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of
King Pharmaceuticals, Inc.today announced that the Company is presenting safety and efficacy data for ACUROX(R)and EMBEDA(TM) (ALO-01), two novel opioid analgesic formulations that are in development, at the 71st Annual Meeting of the...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Th
RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc.today announced that the Company is presenting safety and efficacy data for ACUROX(R) and EMBEDA(TM) (ALO-01), two novel opioid analgesic formulations that are in development,...
|
|
|
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Th
King Pharmaceuticals, Inc.(NYSE: KG) today announced that the Company is presenting safety and efficacy data for ACUROX(R) and EMBEDA(TM) (ALO-01), two novel opioid analgesic formulations that are in development, at the 71st Annual...
|
|
|
Susceptibility Locus in Neurokinin-1 Receptor Gene Associated with Alcohol Dependence
_ Susceptibility Locus in Neurokinin-1 Receptor Gene Associated with Alcohol Dependence.
|
